Family study of blood cell disorders
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at families where more than one person has a blood cell disorder (lymphoproliferative disorder) to understand why it runs in families. If you or a relative have this condition, you may help researchers learn more about it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cell disorder (lymphoproliferative disorder) and a family member also has one.
- You are a blood relative of someone with a blood cell disorder, or you are not related (for the control group).
- You are willing to sign a consent form to join the study.
- You are not pregnant, and you are able to make your own decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at families where more than one close, blood-related person has a lymphoproliferative disorder (a group of conditions where the lymph system makes too many abnormal cells). It aims to better understand why these disorders run in families and how they may be inherited or related.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
This study collects and stores tumor/tissue information and family medical history from people with certain blood cancers. It aims to help researchers understand why these illnesses may run in families and use genetic clues for future research.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
Hear when a new Lymphoproliferative Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.